| Product Code: ETC11227170 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of type 2 diabetes drugs and devices to Finland in 2024 continued to see a diverse range of exporting countries, with Germany, Netherlands, Denmark, Sweden, and the USA leading the pack. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low in 2024, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at 2.88%, reflecting steady expansion. Additionally, the growth rate from 2023 to 2024 was 0.14%, suggesting incremental progress in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Type 2 Diabetes Drugs and Devices Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2022 & 2032F |
3.3 Finland Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 Finland Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.7 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2022 & 2032F |
3.8 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2022 & 2032F |
4 Finland Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of type 2 diabetes in Finland |
4.2.2 Technological advancements in diabetes drugs and devices |
4.2.3 Growing awareness about diabetes management and treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diabetes drugs and devices |
4.3.2 High cost associated with diabetes drugs and devices |
4.3.3 Limited access to diabetes care in remote areas of Finland |
5 Finland Type 2 Diabetes Drugs and Devices Market Trends |
6 Finland Type 2 Diabetes Drugs and Devices Market, By Types |
6.1 Finland Type 2 Diabetes Drugs and Devices Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Oral Drugs, 2022 - 2032F |
6.1.4 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Injectables, 2022 - 2032F |
6.1.5 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Therapy, 2022 - 2032F |
6.1.6 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Combination Therapy, 2022 - 2032F |
6.2 Finland Type 2 Diabetes Drugs and Devices Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Metformin, 2022 - 2032F |
6.2.3 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By SGLT2 Inhibitors, 2022 - 2032F |
6.2.4 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By GLP-1 Agonists, 2022 - 2032F |
6.2.5 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By DPP-4 Inhibitors, 2022 - 2032F |
6.3 Finland Type 2 Diabetes Drugs and Devices Market, By Device Type |
6.3.1 Overview and Analysis |
6.3.2 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Glucose Monitors, 2022 - 2032F |
6.3.3 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.3.4 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By CGMs, 2022 - 2032F |
6.3.5 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Smart Insulin Pens, 2022 - 2032F |
6.4 Finland Type 2 Diabetes Drugs and Devices Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Pharmacies, 2022 - 2032F |
6.4.5 Finland Type 2 Diabetes Drugs and Devices Market Revenues & Volume, By Home Care, 2022 - 2032F |
7 Finland Type 2 Diabetes Drugs and Devices Market Import-Export Trade Statistics |
7.1 Finland Type 2 Diabetes Drugs and Devices Market Export to Major Countries |
7.2 Finland Type 2 Diabetes Drugs and Devices Market Imports from Major Countries |
8 Finland Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed diabetes medications and devices |
8.2 Rate of adoption of advanced diabetes management technologies |
8.3 Number of research and development collaborations for innovative diabetes drugs and devices |
9 Finland Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
9.1 Finland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Finland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.3 Finland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2022 & 2032F |
9.4 Finland Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2022 & 2032F |
10 Finland Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
10.1 Finland Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2025 |
10.2 Finland Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here